The imidazoline receptor in control of blood pressure by clonidine and allied drugs

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 273, Issue 5 42-5, 1997, Pages

  Reis, Donald J ^a   Piletz, John E ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Arterial pressure; Ventrolateral medulla; 2 adrenergic receptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; IMIDAZOLINE; ION CHANNEL; RILMENIDINE;

ARTERIAL PRESSURE; BLOOD PRESSURE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE METABOLISM; DRUG ACTIVITY; HYPERTENSION; HYPOTHESIS; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0030695375     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1997.273.5.r1569     Document Type: Review

References (20)

1. 2-Adrenoceptor-mediated inhibition of bulbospinal barosensitive cells of rat rostral medulla. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R1065-R1075, 1993.
2. Bousquet, P., J. Feldman, and J. Schwartz. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230: 232-236, 1984.
3. 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 273: 1162-1171, 1995.
4. Chan, C. K., F. Sannajust, and G. A. Head. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. J. Pharmacol. Exp. Ther. 276: 411-420, 1996.
5. 1 agents: a new approach to the treatment of hypertension. Ann. NY Acad. Sci. 763: 642-658, 1995.
6. Ernsberger, P., R. Giuliano, R. N. Willette, and D. J. Reis. Role of imidazole receptors in the vasodepressor response to clonidine analogs in rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253: 408-418, 1990.
7. 1-imidazoline binding site in the ventral medulla is a functional receptor mediating vasodepression. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R1572-R1579, 1997.
8. 1-imidazoline binding sites. Neurochem. Int. 30: 17-23, 1997.
9. Gomez, R. E., P. Ernsberger, G. Feinland, and D. J. Reis. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur. J. Pharmacol. 195: 181-191, 1991.
10. Guyenet, P. G. Do imidazoline binding sites play a role in the efficacy of clonidine and related centrally acting sympatholytic drugs? Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R1580-R1584, 1997.
11. Hamilton, C. A., E. Jardine, and J. L. Reid. Downregulation of imidazoline sites in rabbit kidney. Eur. J. Pharmacol. 243: 95-97, 1993.
12. 1-imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 24, Suppl. 1: S1-S8, 1994.
13. Head, G. A. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents. Ann. NY Acad. Sci. 763: 531-540, 1995.
14. 2-adrenoceptors. Br. J. Pharmacol. 110: 1635-1639, 1993.
15. 2-receptors in the hypotensive effect of clonidine. Nature 259: 587-588, 1976.
16. Li, G., S. Regunathan, C. J. Barrow, J. Eshraghi, R. Cooper, and D. J. Reis. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263: 966-969, 1994.
17. 2-adrenergic receptor subtypes b and c. Science 273: 803-805, 1996.
18. 2-adrenergic receptor subtype. Science 273: 801-803, 1996.
19. 1 receptor specific agent. J. Med. Chem. 39: 1193-1195, 1996.
20. Musgrave, I. F., D. Krautwurst, J. Hescheler, and G. Schultz. Clonidine and cirazoline inhibit activation of nicotinic channels in PC-12 cells. Ann. NY Acad. Sci. 763: 272-282, 1995.